Journal of psychopharmacology (Oxford, England)

Keyphrases

Publications

volume 38, number 6, 2024

Reza Rafizadeh, Anmol Sooch, Alessia Risi, Nicoline Bihelek, Kyler Kanegawa, Alasdair M Barr, Randall F White, Christian G Schütz, Chad A Bousman
Impact of patient-specific factors on clozapine metabolism in individuals with treatment-resistant schizophrenia or schizoaffective disorder. Journal of psychopharmacology (Oxford, England) 38 (6) (2024)
Ying Jiang, Yusi Cheng, Zhiqiang Du, Yuan Shen, Qin Zhou, Yingying Ji, Haohao Zhu
Unveiling potential adverse events associated with escitalopram oxalate: A real-world analysis based FDA adverse event reporting system database. Journal of psychopharmacology (Oxford, England) 38 (6) (2024)
Reza Rafizadeh, Anmol Sooch, Alessia Risi, Nicoline Bihelek, Kyler Kanegawa, Alasdair M Barr, Randall F White, Christian G Schütz, Chad A Bousman
Impact of patient-specific factors on clozapine metabolism in individuals with treatment-resistant schizophrenia or schizoaffective disorder. Journal of psychopharmacology (Oxford, England) 38 (6) (2024)
Gavin P Reynolds
The trace amine-associated receptor 1 agonists - non-dopaminergic antipsychotics or covert modulators of D2 receptors? Journal of psychopharmacology (Oxford, England) 38 (6) (2024)
Emily M Gent, Joshua W Bryan, Maisy A Cleary, Tegan I Clarke, Harry D Holmwood, Rania O Nassereddine, Chris Salway, Simon Depla, Sarah Statton, Joy Krecké, Celia Ja Morgan
Esketamine combined with a mindfulness-based intervention for individuals with alcohol problems. Journal of psychopharmacology (Oxford, England) 38 (6) (2024)
Gavin P Reynolds
The trace amine-associated receptor 1 agonists - non-dopaminergic antipsychotics or covert modulators of D2 receptors? Journal of psychopharmacology (Oxford, England) 38 (6) (2024)
Anna Powell, Harry Sumnall, Cecil Kullu, Lynn Owens, Catharine Montgomery
Changes in processing speed during early abstinence from alcohol dependence. Journal of psychopharmacology (Oxford, England) 38 (6) (2024)
Anna Powell, Harry Sumnall, Cecil Kullu, Lynn Owens, Catharine Montgomery
Changes in processing speed during early abstinence from alcohol dependence. Journal of psychopharmacology (Oxford, England) 38 (6) (2024)
Gavin P Reynolds
The trace amine-associated receptor 1 agonists - non-dopaminergic antipsychotics or covert modulators of D2 receptors? Journal of psychopharmacology (Oxford, England) 38 (6) (2024)
Stefano Maddalena, Carlo Magistri, Cristiano Mellini, Giuseppe Sarli
Aripiprazole for treating delirium: A systematic review-Is it a valid yet understudied treatment? Journal of psychopharmacology (Oxford, England) 38 (6) (2024)
Emily M Gent, Joshua W Bryan, Maisy A Cleary, Tegan I Clarke, Harry D Holmwood, Rania O Nassereddine, Chris Salway, Simon Depla, Sarah Statton, Joy Krecké, Celia Ja Morgan
Esketamine combined with a mindfulness-based intervention for individuals with alcohol problems. Journal of psychopharmacology (Oxford, England) 38 (6) (2024)
Reza Rafizadeh, Anmol Sooch, Alessia Risi, Nicoline Bihelek, Kyler Kanegawa, Alasdair M Barr, Randall F White, Christian G Schütz, Chad A Bousman
Impact of patient-specific factors on clozapine metabolism in individuals with treatment-resistant schizophrenia or schizoaffective disorder. Journal of psychopharmacology (Oxford, England) 38 (6) (2024)
Emily M Gent, Joshua W Bryan, Maisy A Cleary, Tegan I Clarke, Harry D Holmwood, Rania O Nassereddine, Chris Salway, Simon Depla, Sarah Statton, Joy Krecké, Celia Ja Morgan
Esketamine combined with a mindfulness-based intervention for individuals with alcohol problems. Journal of psychopharmacology (Oxford, England) 38 (6) (2024)
Kai-Chun Yang, Bang-Hung Yang, Mu-N Liu, Ying-Jay Liou, Yuan-Hwa Chou
Cognitive impairment in schizophrenia is associated with prefrontal-striatal functional hypoconnectivity and striatal dopaminergic abnormalities. Journal of psychopharmacology (Oxford, England) 38 (6) (2024)
Sara de la Salle, Justin Piche, Brittany Duncan, Joelle Choueiry, Molly Hyde, Robert Aidelbaum, Ashley Baddeley, Danielle Impey, Noreen Rahmani, Vadim Ilivitsky, Verner Knott
Influence of GABA A and GABA B receptor activation on auditory sensory gating and its association with anxiety in healthy volunteers. Journal of psychopharmacology (Oxford, England) 38 (6) (2024)
Gavin P Reynolds
The trace amine-associated receptor 1 agonists - non-dopaminergic antipsychotics or covert modulators of D2 receptors? Journal of psychopharmacology (Oxford, England) 38 (6) (2024)

volume 38, number 7, 2024

Jessica M Illenberger, Francisco J Flores-Ramirez, Glenn Pascasio, Marissa Franco, Brandon Mendonsa, Rémi Martin-Fardon
Pivotal role of orexin signaling in the posterior paraventricular nucleus of the thalamus during the stress-induced reinstatement of oxycodone-seeking behavior. Journal of psychopharmacology (Oxford, England) 38 (7) (2024)
David M Taylor, Kalliopi Vallianatou, Shreyans Gandhi, Cecilia Casetta, Oliver Howes, James Hunter MacCabe
Severe neutropenia unrelated to clozapine in patients receiving clozapine. Journal of psychopharmacology (Oxford, England) 38 (7) (2024)
Seyyed Nassir Ghaemi
The pseudoscience of lithium and suicide: Reanalysis of a misleading meta-analysis. Journal of psychopharmacology (Oxford, England) 38 (7) (2024)
Mariusz Papp, Piotr Gruca, Ewa Litwa, Magdalena Lason, Adrian Newman-Tancredi, Ronan Depoortère
The 5-HT1A receptor biased agonists, NLX-204 and NLX-101, like ketamine, elicit rapid-acting antidepressant activity in the rat chronic mild stress model via cortical mechanisms. Journal of psychopharmacology (Oxford, England) 38 (7) (2024)
Amie C Hayley, Brook Shiferaw, Blair Aitken, Joanna Rositano, Luke A Downey
Acute methamphetamine and alcohol usage alters gaze behaviour during driving: A randomised, double-blind, placebo-controlled study. Journal of psychopharmacology (Oxford, England) 38 (7) (2024)
Natalie Schroyens, Laura Vercammen, Burcu Özcan, Victoria Aurora Ossorio Salazar, Jonas Zaman, Dimitri De Bundel, Tom Beckers, Laura Luyten
No evidence that post-training dopamine D2 receptor agonism affects fear generalization in male rats. Journal of psychopharmacology (Oxford, England) 38 (7) (2024)
Natalie Schroyens, Laura Vercammen, Burcu Özcan, Victoria Aurora Ossorio Salazar, Jonas Zaman, Dimitri De Bundel, Tom Beckers, Laura Luyten
No evidence that post-training dopamine D2 receptor agonism affects fear generalization in male rats. Journal of psychopharmacology (Oxford, England) 38 (7) (2024)
Jessica M Illenberger, Francisco J Flores-Ramirez, Glenn Pascasio, Marissa Franco, Brandon Mendonsa, Rémi Martin-Fardon
Pivotal role of orexin signaling in the posterior paraventricular nucleus of the thalamus during the stress-induced reinstatement of oxycodone-seeking behavior. Journal of psychopharmacology (Oxford, England) 38 (7) (2024)
Natalie Schroyens, Laura Vercammen, Burcu Özcan, Victoria Aurora Ossorio Salazar, Jonas Zaman, Dimitri De Bundel, Tom Beckers, Laura Luyten
No evidence that post-training dopamine D2 receptor agonism affects fear generalization in male rats. Journal of psychopharmacology (Oxford, England) 38 (7) (2024)
Marco Di Nicola, Michael Adair, A Rieckmann, Michael Cronquist Christensen
Effectiveness of vortioxetine in elderly patients with major depressive disorder in real-world clinical practice: Results from the RELIEVE study. Journal of psychopharmacology (Oxford, England) 38 (7) (2024)
Catarina Rosada, Renée Lipka, Sophie Metz, Christian Otte, Hauke Heekeren, Katja Wingenfeld
Effects of stress-related neuromodulators on amygdala and hippocampus resting state functional connectivity. Journal of psychopharmacology (Oxford, England) 38 (7) (2024)
Elemer Szabadi
Three paradoxes related to the mode of action of pramipexole: The path from D2/D3 dopamine receptor stimulation to modification of dopamine-modulated functions. Journal of psychopharmacology (Oxford, England) 38 (7) (2024)
Marco Di Nicola, Michael Adair, A Rieckmann, Michael Cronquist Christensen
Effectiveness of vortioxetine in elderly patients with major depressive disorder in real-world clinical practice: Results from the RELIEVE study. Journal of psychopharmacology (Oxford, England) 38 (7) (2024)
Catarina Rosada, Renée Lipka, Sophie Metz, Christian Otte, Hauke Heekeren, Katja Wingenfeld
Effects of stress-related neuromodulators on amygdala and hippocampus resting state functional connectivity. Journal of psychopharmacology (Oxford, England) 38 (7) (2024)
Amie C Hayley, Brook Shiferaw, Blair Aitken, Joanna Rositano, Luke A Downey
Acute methamphetamine and alcohol usage alters gaze behaviour during driving: A randomised, double-blind, placebo-controlled study. Journal of psychopharmacology (Oxford, England) 38 (7) (2024)
Marco Di Nicola, Michael Adair, A Rieckmann, Michael Cronquist Christensen
Effectiveness of vortioxetine in elderly patients with major depressive disorder in real-world clinical practice: Results from the RELIEVE study. Journal of psychopharmacology (Oxford, England) 38 (7) (2024)
Amie C Hayley, Brook Shiferaw, Blair Aitken, Joanna Rositano, Luke A Downey
Acute methamphetamine and alcohol usage alters gaze behaviour during driving: A randomised, double-blind, placebo-controlled study. Journal of psychopharmacology (Oxford, England) 38 (7) (2024)
Catarina Rosada, Renée Lipka, Sophie Metz, Christian Otte, Hauke Heekeren, Katja Wingenfeld
Effects of stress-related neuromodulators on amygdala and hippocampus resting state functional connectivity. Journal of psychopharmacology (Oxford, England) 38 (7) (2024)

volume 38, number 8, 2024

Luke Baxter, Cheneal Puljević, Timothy M Piatkowski, Jason A Ferris, Emma L Davies, Monica J Barratt, Adam Winstock
Tripping into the unknown: Exploring the experiences of first-time LSD users through global drug survey insights. Journal of psychopharmacology (Oxford, England) 38 (8) (2024)
Camilo A Castelblanco, Seth D Springer, Mikki D Schantell, Jason A John, Anna T Coutant, Lucy K Horne, Ryan Glesinger, Jacob A Eastman, Tony W Wilson
Chronic Cannabis users exhibit altered oscillatory dynamics and functional connectivity serving visuospatial processing. Journal of psychopharmacology (Oxford, England) 38 (8) (2024)
Kurt Stocker, Matthias E Liechti
Methylenedioxymethamphetamine is a connectogen with empathogenic, entactogenic, and still further connective properties: It is time to reconcile "the great entactogen-empathogen debate". Journal of psychopharmacology (Oxford, England) 38 (8) (2024)
Philip Todd Korthuis, Kim A Hoffman, Adrianne R Wilson-Poe, Jason B Luoma, Alissa Bazinet, Kellie Pertl, David L Morgan, Ryan R Cook, Sarann Bielavitz, Renae Myers, Robert Cameron Wolf, Dennis McCarty, Christopher S Stauffer
Developing the Open Psychedelic Evaluation Nexus consensus measures for assessment of supervised psilocybin services: An e-Delphi study. Journal of psychopharmacology (Oxford, England) 38 (8) (2024)
Luke Baxter, Cheneal Puljević, Timothy M Piatkowski, Jason A Ferris, Emma L Davies, Monica J Barratt, Adam Winstock
Tripping into the unknown: Exploring the experiences of first-time LSD users through global drug survey insights. Journal of psychopharmacology (Oxford, England) 38 (8) (2024)
Vince Polito, Paul Liknaitzky
Is microdosing a placebo? A rapid review of low-dose LSD and psilocybin research. Journal of psychopharmacology (Oxford, England) 38 (8) (2024)
Roman Palitsky, Deanna M Kaplan, John Perna, Zachary Bosshardt, Jessica L Maples-Keller, Holly F Levin-Aspenson, Ali John Zarrabi, Caroline Peacock, Tanja Mletzko, Barbara O Rothbaum, Charles A Raison, George H Grant, Boadie W Dunlop
A framework for assessment of adverse events occurring in psychedelic-assisted therapies. Journal of psychopharmacology (Oxford, England) 38 (8) (2024)
Luke Baxter, Cheneal Puljević, Timothy M Piatkowski, Jason A Ferris, Emma L Davies, Monica J Barratt, Adam Winstock
Tripping into the unknown: Exploring the experiences of first-time LSD users through global drug survey insights. Journal of psychopharmacology (Oxford, England) 38 (8) (2024)
Vince Polito, Paul Liknaitzky
Is microdosing a placebo? A rapid review of low-dose LSD and psilocybin research. Journal of psychopharmacology (Oxford, England) 38 (8) (2024)
Kurt Stocker, Matthias E Liechti
Methylenedioxymethamphetamine is a connectogen with empathogenic, entactogenic, and still further connective properties: It is time to reconcile "the great entactogen-empathogen debate". Journal of psychopharmacology (Oxford, England) 38 (8) (2024)
Kurt Stocker, Matthias E Liechti
Methylenedioxymethamphetamine is a connectogen with empathogenic, entactogenic, and still further connective properties: It is time to reconcile "the great entactogen-empathogen debate". Journal of psychopharmacology (Oxford, England) 38 (8) (2024)
Claire Walker, Timothy M Piatkowski, Jason A Ferris, Emma Davies, Monica Barratt, Adam Winstock, Cheneal Puljević
From chaos to kaleidoscope: Exploring factors in psychedelic self-treatment for mental health conditions. Journal of psychopharmacology (Oxford, England) 38 (8) (2024)
Vince Polito, Paul Liknaitzky
Is microdosing a placebo? A rapid review of low-dose LSD and psilocybin research. Journal of psychopharmacology (Oxford, England) 38 (8) (2024)
Kurt Stocker, Matthias E Liechti
Methylenedioxymethamphetamine is a connectogen with empathogenic, entactogenic, and still further connective properties: It is time to reconcile "the great entactogen-empathogen debate". Journal of psychopharmacology (Oxford, England) 38 (8) (2024)
Claire Walker, Timothy M Piatkowski, Jason A Ferris, Emma Davies, Monica Barratt, Adam Winstock, Cheneal Puljević
From chaos to kaleidoscope: Exploring factors in psychedelic self-treatment for mental health conditions. Journal of psychopharmacology (Oxford, England) 38 (8) (2024)
Claire Walker, Timothy M Piatkowski, Jason A Ferris, Emma Davies, Monica Barratt, Adam Winstock, Cheneal Puljević
From chaos to kaleidoscope: Exploring factors in psychedelic self-treatment for mental health conditions. Journal of psychopharmacology (Oxford, England) 38 (8) (2024)